Proceedings of the First International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: summary consensus statement.

Aman U. Buzdar, Steven E. Come, 2 Angela Brodie, Matthew Ellis, Paul E. Goss, James N. Ingle, Stephen R. D. Johnston, Adrian V. Lee, C. Kent Osborne, Victor G. Vogel, and Carol S. Hart University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-4009 [A. U. B.]; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215 [S. E. C.]; Department of Pharmacology, University of Maryland Medical School, Baltimore, Maryland 21201 [A. B.]; Medical Oncology, Princess Margaret Hospital, M5G 2 M9 Toronto, Ontario, Canada [P. E. G.]; Duke University Medical Center, Durham, North Carolina 27710 [M. E.]; Department of Medicine, Royal Marsden Hospital and Institute of Cancer Research, SW3 6JJ London, United Kingdom [S. R. D. J.]; Department of Oncology, Mayo Clinic, Rochester, Minnesota 55905-0001 [ J. N. I.]; Breast Center, Baylor College of Medicine, Houston, Texas 77030 [A. V. L., C. K. O.]; MageeFUPCI Breast Program, Magee Womens Hospital, Pittsburgh, Pennsylvania 15213-3180 [V. G. V.]; and InforMEDical, Narberth, Pennsylvania 19072-2229 [C. S. H.]